You are here

Advisory Board Solidified with PotNetwork Holding, Inc.’s Appointment of Distinguished South Florida Cardiovascular Specialist

August 10, 2017

Potnetwork Holding, Inc is pleased to announce today, in consideration of management’s strategy to formulate, produce, and market a spectrum of exclusive and diversely targeted cannabidiol blends, that they have formed an advisory board to provide Diamond CBD with guidance and insight on upcoming formulations. Ultimately planned to consist of physicians and medical cannabis specialists, the first appointment was the distinguished Dr. Mark G. Sabbota.

Dr. Sabbota’s credentials include Board Certification in both Internal Medicine and Cardiology. He brings to the Company a wealth of experience and is expected to be a valued contributor, having a comprehensive understanding of Cannabinoid attributes and corresponding knowledge based on research studies, along with Controlled Substance and DEA Licensure. “We want to extend an enthusiastic welcome to Dr. Sabbota and look forward to having his insight as we continue the development of our targeted product lines. We’re developing a diverse and hand selected committee of professionals that will strengthen our competitive advantage by providing valuable cutting-edge guidance, and look forward with great anticipation to future growth with the contributions by the accomplished and esteemed Dr. Sabbota, and fellow experts joining our Board,” stated Maria Gomez, Regional Vice President of Sales of Diamond CBD, Inc.

“I am looking forward to extensive collaboration with the Diamond CBD team. It’s an advantageous time to be involved with such a visionary and motivated group. Diamond CBD’s formulas are premium and revolutionary. To be on board with a team so diligent and focused on leading in the industry is an exciting endeavor,” stated Mark G. Sabbota, Doctor of Osteopathic Medicine.

Dr. Sabbota received his medical degree from Chicago College of Osteopathic Medicine, at Midwestern University. He completed a transitional internship and internal medicine residency and cardiology fellowship at Botsford General Hospital. Dr. Sabbota completed additional training in cardiology at the University of Michigan.

CBD has revealed, through anecdotal research, the potential to contain great healing attributes. Treatments utilizing hemp-derived Cannabis are shown to be effective in relieving symptoms of a wide range of critical conditions, including: rheumatoid arthritis, diabetes, alcoholism, PTSD, epilepsy, antibiotic-resistant infections, neurological disorders, and muscular dystrophy, among many others.

The trend of record breaking quarterly revenues continues with strong momentum. Demonstrating Management’s determined commitment to achieve strong results, Diamond CBD has reported that the past six months of trade show, expo, and convention attendance had yielded product demand requiring significant expansion of its manufacturing operations, which the Company is managing successfully. The Company plans to keep shareholders updated as events progress with its new product lines and other projects currently in process.

About Diamond CBD Inc.: Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD's team consists of hemp industry pioneers and natural product experts, chemists, and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils and E-Liquids found anywhere. For more information, please visit its website at

About PotNetwork Holding Inc: PotNetwork Holding, Inc. (OTC PINK: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.